Today, @ProfluentBio and @EliLillyandCo announce a multi-$B partnership to use our AI models to design custom recombinases, a new class of gene editor capable of large-scale DNA editing across multiple diseases. I'm so proud of the team – Profluent is an n=1 company.
Profluent and Eli Lilly Partner on AI-Designed Gene Editors
By
–
